Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 14(5): e0214152, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31095572

RESUMO

Progestin-only long-acting reversible contraceptives (LARCs) are increasingly popular among women seeking contraception; however, recent epidemiological studies suggest that systemically administered medroxyprogesterone acetate (MPA) may increase HIV acquisition. In order to determine the exact mechanisms underlying increases in transmission specific to MPA use and to test safer, alternative contraceptive progestin types and delivery methods, in vitro modeling studies must be performed. To achieve this, it is imperative that accurate hormone concentrations be utilized when modeling progestin-mediated outcomes, as the down-stream effects are dose-dependent. The local concentrations of progestins to which the lower female genital tract tissues are exposed after initiation of LARCs are unknown, but they likely differ from peripheral concentrations, dependent upon the progestin type and delivery method. Here, we measured in vivo endocervical and plasma concentrations of (1) systemically-delivered depo MPA (DMPA), (2) levonorgestrel (LNG) delivered via intrauterine system (IUS) and (3) etonogestrel (ETG) delivered via vaginal ring in women who recently initiated contraception treatment. Levels of ETG and LNG in cervical secretions were 100-200 fold higher than plasma levels. In contrast, measurable MPA levels were approximately 10-fold higher in plasma compared to cervical secretions. These results will inform the design of accurate in vitro studies on the influence of progestins on epithelial cells, tissue explants, and peripheral blood cells, to be able to better predict in vivo outcomes. Subsequent observations will aid in determining how MPA might influence HIV acquisition and may facilitate identification of optimal progestin-containing LARC alternatives for women at high risk for HIV infection.


Assuntos
Anticoncepcionais Femininos/administração & dosagem , Infecções por HIV/prevenção & controle , Progestinas/administração & dosagem , Adolescente , Adulto , Colo do Útero/efeitos dos fármacos , Colo do Útero/virologia , Anticoncepção/efeitos adversos , Anticoncepcionais Femininos/efeitos adversos , Desogestrel/administração & dosagem , Feminino , Humanos , Levanogestrel/administração & dosagem , Acetato de Medroxiprogesterona/administração & dosagem , Adulto Jovem
2.
Breastfeed Med ; 10(9): 419-24, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26394021

RESUMO

BACKGROUND: Chemicals inhaled or ingested by mothers can be present in their milk. Our objective was to determine levels of nicotine, cotinine, and caffeine in human milk purchased via the Internet. MATERIALS AND METHODS: We purchased human milk (n=102) via the Internet and abstracted seller advertisements for information volunteered about tobacco and caffeine use. Nicotine, cotinine, and caffeine levels in the milk were quantified by mass spectrometry according to published protocols. RESULTS: No sellers indicated smoking in their advertisement. Many of the milk samples (58%) had detectable nicotine or cotinine; four (4%) of the samples had nicotine or cotinine levels high enough to indicate active smoking. Twelve (12%) sellers said in their advertisements that they specifically limit (4%) or avoid (8%) caffeine entirely. Five (5%) of the samples had caffeine levels consistent with consuming at least 1 cup of coffee 2 hours prior to milk expression. Detectable amounts of caffeine were found in almost all of the samples (97%). CONCLUSIONS: In 102 milk samples, we detected evidence of active smoking, secondhand smoke exposure, and almost ubiquitous caffeine consumption. Buyers of human milk on the Internet should be aware that advertisements do not always include accurate information as to what substances may be present. Sellers may misrepresent their health behaviors or be unaware of lifestyle factors that can lead to exposure to nicotine and caffeine.


Assuntos
Comércio , Seleção do Doador/métodos , Internet , Bancos de Leite Humano , Leite Humano/química , Adulto , Cafeína/metabolismo , Cotinina/metabolismo , Feminino , Humanos , Lactente , Fenômenos Fisiológicos da Nutrição do Lactente , Recém-Nascido , Masculino , Espectrometria de Massas , Nicotina/metabolismo , Fumar , Nicotiana/metabolismo , Poluição por Fumaça de Tabaco , Revelação da Verdade
3.
Curr Protoc Toxicol ; 58: Unit 17.16., 2013 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-24510541

RESUMO

Arginine is the substrate for nitric oxide synthases (NOS), and arginine availability regulates the production of nitric oxide. Through the activity of methyltransferases, arginine can be methylated to form monomethylarginine (NMMA), asymmetrical dimethylarginine (ADMA), and symmetrical dimethylarginine (SDMA). NMMA and ADMA directly inhibit NOS, whereas SDMA inhibits the cellular import of arginine through the cationic amino acid transporter. Increased levels of methylarginine compounds have been associated with many diseases including atherosclerosis, renal failure, pulmonary hypertension, and preeclampsia. Previous HPLC methods to measure these molecules rely on derivatization with ortho-phthalaldehyde, which is unstable and requires immediate pre- or post-column reactions. We have identified a new fluorometric agent that is stable for at least 1 week and provides chromatographic properties that facilitate separation of these chemically similar compounds by reverse phase chromatography.


Assuntos
Arginina/análise , Arginina/metabolismo , Cromatografia Líquida de Alta Pressão/métodos , Extração em Fase Sólida/métodos , Arginina/sangue , Arginina/urina , Calibragem , Humanos , Manejo de Espécimes
4.
Eur J Pediatr ; 170(7): 859-63, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21120524

RESUMO

Down syndrome (DS) patients have an increased risk of developing pulmonary hypertension (PH). Increased plasma levels of asymmetric dimethylarginine (ADMA) may contribute to vascular dysfunction in adults with idiopathic pulmonary hypertension. Our goal was to test the hypothesis that DS patients with PH have higher plasma levels of ADMA than DS patients without PH. DS patients with definitive PH (n = 6) and DS patients with no evidence of PH (n = 12) were studied. Plasma levels of arginine, ADMA, and nitrite/nitrate (NOx; stable metabolites of nitric oxide (NO)) were measured. Plasma arginine concentration was lower (p < 0.05) in PH patients (23 ± 11 µM) versus non-PH patients (46 ± 24 µM). Plasma ADMA concentration was higher (p < 0.005) in PH patients (18.0 ± 4.2 µM) versus non-PH patients (8.6 ± 5.9 µM). Plasma NOx was lower (p < 0.05) in PH patients (4.5 ± 1.7 µM) versus non-PH patients (8.5 ± 7.3 µM). These results are consistent with ADMA contributing to lower NO production in DS patients with PH and suggest that ADMA levels may be a potential biomarker for PH in DS patients.


Assuntos
Arginina/análogos & derivados , Síndrome de Down/sangue , Hipertensão Pulmonar/sangue , Arginina/sangue , Biomarcadores/sangue , Síndrome de Down/complicações , Feminino , Humanos , Hipertensão Pulmonar/complicações , Lactente , Masculino , Nitratos/sangue , Nitritos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...